ApoLife |
|
||
| ApoLife has developed platform yeast expression technologies for accelerated development of therapeutic antibodies (glycosylated and aglycosylated), antibody fragments, fusion proteins and next generation antibodies and subunit vaccines through its proprietary Twin Cassette yeast system. | |||
| Address: | 100 River Place, Suite #6850 | ||
| City: | Detroit | ||
| State/Province: | Michigan | ||
| Postcode: | 48207 | ||
| Country: | USA | ||
